ABBOTT LABORATORIES — Director's Dealing 2007

Dec 13, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-12-11

Reporting Person: FREYMAN THOMAS C (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-12-11	Common shares without par value	M	11767	$46.9196	Acquired	301965	Direct
2007-12-11	Common shares without par value	M	29290	$46.65	Acquired	331255	Direct
2007-12-11	Common shares without par value	F	35920	$58.90	Disposed	295335	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-12-11	Option (right to buy)	$46.9196	M	11767	Disposed	2010-02-10	common shares (11767)	Direct
2007-12-11	Option (right to buy)	$46.65	M	29290	Disposed	2013-02-13	common shares (29290)	Direct
2007-12-11	Option (right to buy)	$58.90	A	10318	Acquired	2010-02-10	common shares (10318)	Direct
2007-12-11	Option (right to buy)	$58.90	A	25602	Acquired	2013-02-13	common shares (25602)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	19759	Indirect
Common shares without par value	845	Indirect
Common shares without par value	845	Indirect
Common shares without par value	845	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 10, 2007.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter and sons.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.